Then, cells can be imaged directly on the magnetic sifter array and harvested by moving out the field and washing. Improvements include higher efficiency in capture with better throughput, rapid imaging of captured cells, and harvesting of viable cells, avoiding the loss of cells in preparatory steps, compared with other methods.Importantly, a portable device (CellCollector?, GILUPI NanoMedizin, Potsdam, Germany) based on EpCAM expression has been developed in the last years. This medical system showed high specificity and sensitivity for isolation of CTCs in vivo from circulating peripheral blood of breast cancer or non-small cell lung cancer (NSCLC) patients. The system is inserted through a standard venous cannula into the cubital vein for 30 min.
After the enrichment step, CTCs are identified by EpCAM and/or cytokeratin expression [31]. This device is considered a promising tool for monitoring the course of the cancer disease and the efficacy of anticancer treatment in vivo.2.2. Physical PropertiesCTCs could be also separated from blood cells according to their size. Isolation based on cell size has two main advantages: a higher capture efficiency and independence of antigen expression. When epithelia-mesenchymal transition (EMT) takes place as the step previous to metastasis, some epithelial markers are lost [65]. We have recently described the acquisition of a plasticity and stemness phenotype in CTCs from endometrial cancer patients, probab
The widespread use of information and communication technologies in today’s medical and health services, usually described by the term eHealth, is drastically changing the face of healthcare delivery.
More recently, the rapid advances in mobile and wireless communications offering almost ubiquitous and continuous connectivity through intelligent mobile devices, such as smartphones, tablets, personal digital assistants (PDAs), etc., have added a new component to the eHealth paradigm, known as mHealth [1]. A broad range of eHealth/mHealth scenarios with benefits for both patients and healthcare providers are envisioned, including remote patient monitoring, active management of chronic diseases, such as diabetes, support for independent aging to the elderly and the tracking of personal fitness activities to improve health and well-being [2].
A number of small and autonomous medical sensor devices, either wearable or implantable, are usually employed at the patient’s Anacetrapib side. Each sensor is typically highly specialized to perform a specific task, such as collecting patient’s vital signs (e.g., body temperature, brain activity, heart rate, etc.), measuring external parameters (e.g., ambient temperature, motion patterns, patient location, etc.) or even performing specific actions (e.g., the administration of a specific dosage of insulin). The sensors are usually connected to a sink central device that acts as a coordinator (i.e.